The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...
The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral treatment for ...
The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...
17h
FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
The U.S. is considering allowing bemotrizinol, a highly effective UV filter used throughout Europe and Asia, in its sunscreen ...
Indonesia and the Netherlands have agreed to repatriate two Dutch nationals convicted on drug offenses in Indonesia. One ...
A new FDA approval for a first-in-class drug has vaulted Otsuka into immunoglobulin A nephropathy (IgAN), an increasingly competitive kidney disease field targeted by multiple biopharma companies. The ...
Sibeprenlimab is approved for IgAN treatment, showing a 51.2% reduction in proteinuria in the VISIONARY trial. Administered subcutaneously every four weeks, it inhibits APRIL to reduce IgA levels.
Honey Singh’s Strong Advice to Youth Against Drug Abuse ‘He injected me with mercury’: Bengaluru woman's ‘poisonous’ death puts businessman in soup Naga Chaitanya lived with mom, got to know him when ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Richard Pazdur, the new director of the Center for Drug Evaluation and Research, raised concerns amid the rollout of several FDA initiatives seeking to shorten the drug review process. Richard Pazdur, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback